4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000027
CFO and Secretary sold 96,815 shares at $12.94 ($1,252,718)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Adam Scott CFO and Secretary | 2024-06-11 | Sale 10b5-1 | −96,815 | $12.94 | $1,252,718 | 255,462 | D |
| Open-market sales · 96,815 sh · avg $12.94 · $1,252,718 | |||||||
Loading xslF345X05/wk-form4_1718314405.xml…